148 related articles for article (PubMed ID: 37665069)
41. Surgical effects of type-I thyroplasty and fat injection laryngoplasty on voice recovery.
Hasukawa A; Mochizuki R; Sakamoto H; Shibano A; Kitahara T
Auris Nasus Larynx; 2021 Apr; 48(2):302-309. PubMed ID: 32958328
[TBL] [Abstract][Full Text] [Related]
42. Inpatient Type 1 Thyroplasty Versus Injection Laryngoplasty for Vocal Fold Movement Impairment After Extent type I and II Aortic Repair.
Pinzas LA; Chen DW; Liou NE; Donovan DT; Ongkasuwan J
Ann Otol Rhinol Laryngol; 2022 Dec; 131(12):1340-1345. PubMed ID: 35016531
[TBL] [Abstract][Full Text] [Related]
43. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
Stow NW; Lee JW; Cole IE
Otolaryngol Head Neck Surg; 2012 Feb; 146(2):266-71. PubMed ID: 22075075
[TBL] [Abstract][Full Text] [Related]
44. Objective Laryngoscopic Measures From Older Patients With Voice Complaints and Signs of Aging.
Stager SV; Gupta S; Amdur R; Bielamowicz SA
J Speech Lang Hear Res; 2021 Dec; 64(12):4705-4717. PubMed ID: 34735274
[TBL] [Abstract][Full Text] [Related]
45. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
[TBL] [Abstract][Full Text] [Related]
46. Arytenoid vertical height discrepancy in predicting outcomes after unilateral vocal cord medialization.
Wong E; Smith M; Stone DB; Palme CE; Smith MC; Riffat F
Laryngoscope; 2020 Feb; 130(2):418-422. PubMed ID: 30843620
[TBL] [Abstract][Full Text] [Related]
47. Acoustics and aerodynamic effects following glottal and infraglottal medialization in an excised larynx model.
Oren L; Maddox A; Farbos de Luzan C; Xie C; Howell R; Dion G; Gutmark E; Khosla S
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2523-2529. PubMed ID: 38421393
[TBL] [Abstract][Full Text] [Related]
48. The role of diode laser in the treatment of ventricular dysphonia.
Liu SC; Lin DS; Su WF
J Voice; 2013 Mar; 27(2):250-4. PubMed ID: 23280382
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of type I thyroplasty after endoscopic cordectomy for early-stage glottic cancer: Literature review.
Bertelsen C; Reder L
Laryngoscope; 2018 Mar; 128(3):690-696. PubMed ID: 29314074
[TBL] [Abstract][Full Text] [Related]
50. The biomechanics of the medialization laryngoplasty (thyroplasty type 1) in an ex vivo canine model.
Noordzij JP; Opperman DA; Perrault DF; Woo P
J Voice; 1998 Sep; 12(3):372-82. PubMed ID: 9763188
[TBL] [Abstract][Full Text] [Related]
51. Voice and laryngeal configuration of men with unilateral vocal fold paralysis before and after medialization.
Schwarz K; Cielo CA; Steffen N; Becker J; Jotz GP
J Voice; 2011 Sep; 25(5):611-8. PubMed ID: 20951549
[TBL] [Abstract][Full Text] [Related]
52. Medialization thyroplasty using autologous nasal septal cartilage for treating unilateral vocal fold paralysis.
Mesallam TA; Khalil YA; Malki KH; Farahat M
Clin Exp Otorhinolaryngol; 2011 Sep; 4(3):142-8. PubMed ID: 21949581
[TBL] [Abstract][Full Text] [Related]
53. Medialization Thyroplasty and Arytenoid Adduction for Management of Neurological Vocal Fold Immobility.
Prasad VMN; Remacle M
Adv Otorhinolaryngol; 2020; 85():85-97. PubMed ID: 33166967
[TBL] [Abstract][Full Text] [Related]
54. Correlation among the dysphonia severity index (DSI), the RBH voice perceptual evaluation, and minimum glottal area in female patients with vocal fold nodules.
Hussein Gaber AG; Liang FY; Yang JS; Wang YJ; Zheng YQ
J Voice; 2014 Jan; 28(1):20-3. PubMed ID: 24275460
[TBL] [Abstract][Full Text] [Related]
55. Treatment of aging vocal folds: surgical approaches.
Seino Y; Allen JE
Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):466-71. PubMed ID: 25160615
[TBL] [Abstract][Full Text] [Related]
56. Surgical Impact of the Montgomery Implant System on Arytenoid Cartilage and the Paralyzed Vocal Fold.
Storck C; Lüthi M; Honegger F; Unteregger F
J Voice; 2020 Jan; 34(1):145-149. PubMed ID: 30172670
[TBL] [Abstract][Full Text] [Related]
57. Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty.
Balouch B; Maxwell PJ; Vontela S; Sataloff RT
J Voice; 2023 Nov; ():. PubMed ID: 37940421
[TBL] [Abstract][Full Text] [Related]
58. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty.
Shen T; Damrose EJ; Morzaria S
Otolaryngol Head Neck Surg; 2013 Feb; 148(2):197-208. PubMed ID: 23077153
[TBL] [Abstract][Full Text] [Related]
59. Using peak direct subglottic pressure level as an objective measure during medialization thyroplasty: a prospective study.
Almohizea MI; Prasad VM; Fakhoury R; Bihin B; Remacle M
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2607-11. PubMed ID: 27139700
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and Long-term Consequences of Vocal Fold Hemorrhage in Patients who Underwent Microscopic Laryngeal Surgery or Type I Thyroplasty.
Paknezhad H; Pasick LJ; Sataloff RT
J Voice; 2021 Jan; 35(1):143-150. PubMed ID: 31362845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
